title: Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban.
authors: Şişli Hamidiye Etfal Training and Research Hospital, Clinic of Nephrology, İstanbul, Turkey E-mail: nbhasbal@gmail.com.
authors: Nuri Barış
authors: NB
authors: Hasbal
authors: Taner
authors: T
authors: Baştürk
authors: Yener
authors: Y
authors: Koç
authors: Tuncay
authors: T
authors: Sahutoğlu
authors: Feyza
authors: F
authors: Bayrakdar Çağlayan
authors: Abdülkadir
authors: A
authors: Ünsal
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011693:Purpura / Q000188:drug therapy* / Q000473:pathology; D000069552:Rivaroxaban / Q000009:adverse effects* / Q000627:therapeutic use; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000925:Anticoagulants; D000069552:Rivaroxaban